...
首页> 外文期刊>British Journal of Cancer >Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells
【24h】

Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells

机译:地塞米松降低MAT 13762大鼠乳腺癌细胞中尿激酶纤溶酶原激活剂mRNA的稳定性

获取原文

摘要

The glucocorticoid dexamethasone was observed to decrease urokinase plasminogen activator (uPA) RNA levels from within 1 h of treatment of MAT 13762 mammary adenocarcinoma cells. The drug did not alter the rate of uPA gene transcription in these cells, but decreased the stability of cytoplasmic uPA mRNA transcripts. Results from cycloheximide and actinomycin D experiments indicated that the dexamethasone-mediated reduction in uPA RNA required both new protein and RNA synthesis. Based on these results, we propose that dexamethasone induces a short-lived protein(s) which down-regulates uPA RNA levels post-transcriptionally in these metastatic tumour cells.
机译:在治疗MAT 13762乳腺腺癌细胞后1小时内,糖皮质激素地塞米松可降低尿激酶纤溶酶原激活剂(uPA)RNA水平。该药物未改变这些细胞中uPA基因转录的速率,但降低了细胞质uPA mRNA转录物的稳定性。环己酰亚胺和放线菌素D实验的结果表明,地塞米松介导的uPA RNA还原需要新的蛋白质和RNA合成。基于这些结果,我们建议地塞米松诱导一种短命蛋白,其在这些转移性肿瘤细胞中转录后下调uPA RNA水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号